|
Variables
|
lncRNA-HEGBC
|
Chi-square
|
P-valueb
|
|---|
|
Low
|
Higha
| | |
|---|
|
All cases
|
51
|
51
| | |
|
Age
| | |
0.634
|
0.426
|
|
≥ 60
|
30
|
26
| | |
|
< 60
|
21
|
25
| | |
|
Gender
| | |
0.367
|
0.545
|
|
Male
|
19
|
22
| | |
|
Female
|
32
|
29
| | |
|
Serum total bilirubin
| |
0.706
|
0.401
|
|
≥ 17.1 μM
|
15
|
19
| | |
|
< 17.1 μM
|
36
|
32
| | |
|
CA19–9
| | |
2.519
|
0.113
|
|
Positive (≥37 U/ml)
|
23
|
31
| | |
|
Negative (< 37 U/ml)
|
28
|
20
| | |
|
Tumor differentiation
| | |
0.158
|
0.691
|
|
Well-moderately
|
29
|
27
| | |
|
Poorly
|
22
|
24
| | |
|
T status
| | |
62.769
|
0.000
|
|
T1 + T2
|
45
|
5
| | |
|
T3 + T4
|
6
|
46
| | |
|
N status
| | |
48.337
|
0.000
|
|
N0
|
45
|
10
| | |
|
N1 + N2
|
6
|
41
| | |
|
TNM stage
| | |
54.440
|
0.000
|
|
I-II
|
41
|
4
| | |
|
III-IV
|
10
|
47
| | |
- aThe median expression level of HEGBC was used as the cutoff
- bPearson chi-square tests were used to analyze the correlation between the expression levels of HEGBC and clinical features
